This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
27 Dec 2025

Hyaza-BFS Sodium hyaluronate Joint injection

Indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative nonpharmacologic therapy and to simple analgesics, eg, acetaminophen.

CompositionSodium hyaluronate 10 mg/ml

Dosage Form
Solution for injection

Indication 
Indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative nonpharmacologic therapy and to simple analgesics, eg, acetaminophen.

Dosage Adminstration
The usual dosage is 2.5 ml of Hyaza - BFS (25 mg of sodium hyaluronate) once a week for 3-5 weeks. Treatment can be repeated, usually, from 6 to 12 months. It is possible to conduct treatment at the same time with more than 1 joint position.Hyaza - BFS is injected directly into the jointIf there is phenomenon of joint effusion, it is necessary to aspirate before injection.For the first 48 hours after injection, patients should rest, avoid strong physical activity in the area where the injection was given.

Mentioned Companies
Ha Noi CPC1 Pharmaceutical Joint Stock Company
View company profile